Aromasin
Sponsors
Pfizer
Conditions
Breast CancerBreast NeoplasmsInvasive Early Breast Cancer
Unknown Phase
An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin
TerminatedNCT00776659
Start: 2008-12-31End: 2012-09-30Updated: 2013-11-19
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer
CompletedNCT01047358
Start: 2010-06-30End: 2014-06-30Updated: 2015-10-08
A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast Cancer
TerminatedNCT01121549
Start: 2010-02-28End: 2012-12-31Updated: 2014-01-22
Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer
TerminatedNCT01239745
Start: 2011-04-30End: 2011-10-31Updated: 2012-10-31
A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients
TerminatedNCT01305239
Start: 2008-10-31End: 2011-05-31Updated: 2012-04-10